Lars Ingvar Viberger
Directeur/Bestuurslid bij Olligon AB
Profiel
Lars Ingvar Viberger is currently a Director at Olligon AB and Robigus AB.
He previously held Director positions at BioGaia AB, Novavax AB, Dynal Biotech AS, IDL Biotech AB, Layerlab AB, Biomolex AS, SVANOVA Biotech AB, Innoventus Project AB, and Peptonic Medical AB.
He was also a Vice President of Research and Development at Amersham Pharmacia Biotech Corp.
Dr. Viberger holds a doctorate degree from the University of Uppsala and undergraduate and graduate degrees from the Swedish University of Agricultural Sciences.
Actieve functies van Lars Ingvar Viberger
| Bedrijven | Functie | Begin |
|---|---|---|
| Olligon AB | Directeur/Bestuurslid | - |
| Robigus AB | Directeur/Bestuurslid | - |
Eerdere bekende functies van Lars Ingvar Viberger
| Bedrijven | Functie | Einde |
|---|---|---|
Biostapro AB
 Biostapro AB Miscellaneous Commercial ServicesCommercial Services Biostapro AB provides vaccine research. It develops human monoclonal antibodies against Staphylococcal and bacterial infections. The company is located in Uppsala, Sweden. | President | 28-07-2011 |
SVANOVA Biotech AB
 SVANOVA Biotech AB Medical SpecialtiesHealth Technology Svanova offers a wide range of products for diagnosing infectious diseases in livestock and companion animals. Used in large-scale laboratories as well as by clinical and practical veterinarians, the majority of its products are based on the ELISA technology and marketed under the trade name SVANOVIR®. This method detects antibodies against different microorganisms, such as viruses, bacteria, parasites or mycoplasmas in various animal species. Svanova's products are available for national and international health issues. Several of its tests, notably BVDV-Ab, IBR-Ab, BLV gp51-Ab and PRV-Ab has been successfully applied in eradication and control programs in countries including Sweden, Finland, Norway, Germany and Austria | Directeur/Bestuurslid | 28-07-2011 |
Dynal Biotech AS
 Dynal Biotech AS Pharmaceuticals: MajorHealth Technology Dynal Biotech has pioneered biomagnetic separation technology since 1986. First invented by Prof. John Ugelstad in 1979.Over the years,it has worked in close collaboration with a variety of customers to develop customised Dynabeads that meet specific application- or regulatory requirements. | Directeur/Bestuurslid | 05-09-2007 |
| Amersham Pharmacia Biotech Corp. | Hoofd Techniek/Wetenschap/O&O | 01-01-2001 |
| PEPTONIC MEDICAL AB | Directeur/Bestuurslid | - |
Opleiding van Lars Ingvar Viberger
| University of Uppsala | Doctorate Degree |
| Swedish University of Agricultural Sciences | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BIOINVENT INTERNATIONAL AB | Health Technology |
| BIOGAIA AB | Health Technology |
| PEPTONIC MEDICAL AB | Health Technology |
| Bedrijven in privébezit | 12 |
|---|---|
BioGaia Fermentation AB
 BioGaia Fermentation AB BiotechnologyHealth Technology Part of Novonesis A/S, BioGaia Fermentation AB is a Swedish company that provides fermentation services. The company is located in Sweden. The CEO of the company is Harald Skogman. BioGaia Fermentation was acquired by Novozymes A/S from BioGaia AB on July 02, 2002. | Health Technology |
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Health Technology |
Dynal Biotech AS
Dynal Biotech AS Pharmaceuticals: MajorHealth Technology Dynal Biotech has pioneered biomagnetic separation technology since 1986. First invented by Prof. John Ugelstad in 1979.Over the years,it has worked in close collaboration with a variety of customers to develop customised Dynabeads that meet specific application- or regulatory requirements. | Health Technology |
IDL Biotech AB
 IDL Biotech AB Medical SpecialtiesHealth Technology IDL Biotech AB engages in the development, production and marketing of in vitro diagnostic tests for the healthcare sector. The firm is active in the fields of Oncology and Bacteriology, manufacturing various tumor markers and a rapid Salmonella Typhoid test. Its products include TPS, TPAcyk, UBC, Monototal, and Tubex. The company was founded in 1988 and is headquartered in Bromma, Sweden. | Health Technology |
Layerlab AB
 Layerlab AB Pharmaceuticals: MajorHealth Technology Layerlab AB is a supplier of lipid membrane immobilization technology for protein analyses, in particular for use in drug discovery. It will primarily supply commercial and academic researchers with immobilization kits for various applications, such as protein interaction studies using biosensors or assembly of protein arrays. Layerlab is aiming to support drug researchers and developers by supplying enabling immobilization technologies for the analysis of membrane bound and associated biomolecules in biosensor instruments. The company was founded in 2002 and is headquartered in Göteborg, Sweden. | Health Technology |
Biomolex AS
 Biomolex AS Medical SpecialtiesHealth Technology Biomolex AS develops and delivers imaging systems for digital autoradiography. It offers Biomolex 700, a digital imager for protein micro-array analysis, including kinase analyses, protein interaction assays, single istotope deoxyribonucleic acid array analyses, micro analyses; and tissue imaging applications, such as foreign genetic material delivery, tissue specific distributions, uptake of antibodies, and uptake of labeled bio-molecules. The company was founded in May 2001 and is headquartered in Oslo, Norway. | Health Technology |
SVANOVA Biotech AB
SVANOVA Biotech AB Medical SpecialtiesHealth Technology Svanova offers a wide range of products for diagnosing infectious diseases in livestock and companion animals. Used in large-scale laboratories as well as by clinical and practical veterinarians, the majority of its products are based on the ELISA technology and marketed under the trade name SVANOVIR®. This method detects antibodies against different microorganisms, such as viruses, bacteria, parasites or mycoplasmas in various animal species. Svanova's products are available for national and international health issues. Several of its tests, notably BVDV-Ab, IBR-Ab, BLV gp51-Ab and PRV-Ab has been successfully applied in eradication and control programs in countries including Sweden, Finland, Norway, Germany and Austria | Health Technology |
| Olligon AB | |
| Robigus AB | |
Innoventus Project AB
 Innoventus Project AB Miscellaneous Commercial ServicesCommercial Services Innoventus Project AB engages in the development and commercialization of ideas, projects, and patents in life science. The company was founded on October 6, 2001 and is headquartered in Uppsala, Sweden. | Commercial Services |
| Amersham Pharmacia Biotech Corp. | |
Biostapro AB
Biostapro AB Miscellaneous Commercial ServicesCommercial Services Biostapro AB provides vaccine research. It develops human monoclonal antibodies against Staphylococcal and bacterial infections. The company is located in Uppsala, Sweden. | Commercial Services |
